Indication
Malaria caused by Plasmodium vivax
9 clinical trials
6 products
Clinical trial
Reducing the Risk of P. Vivax After Falciparum Infections in Co-endemic Areas - a Randomized Controlled TrialStatus: Completed, Estimated PCD: 2022-05-14
Product
primaquineClinical trial
A Revised Tafenoquine Dose to Improve Radical Cure for Vivax Malaria - TAfenoquine DOsing REvisedStatus: Not yet recruiting, Estimated PCD: 2027-03-01
Product
TafenoquineProduct
PrimaquineClinical trial
Monitoring Therapeutic Efficacy of Chloroquine Plus Primaquine in the Treatment of Uncomplicated Plasmodium Vivax Based on Clinical, Parasitologic and Hematologic Parameters in Shecha Health Center: Open Label Clinical TrialStatus: Completed, Estimated PCD: 2023-03-13
Product
ChloroquineClinical trial
Feasibility of High Daily Dose Short Course Primaquine After G6PD Testing for the Radical Cure of Plasmodium Vivax MalariaStatus: Recruiting, Estimated PCD: 2025-05-31
Clinical trial
Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and Primaquine - a Randomized Controlled Trial in P. Vivax PatientsStatus: Recruiting, Estimated PCD: 2024-09-30
Clinical trial
Efficacy and Safety of Chloroquine for Plasmodium Vivax in the Philippines in 2016.Status: Completed, Estimated PCD: 2016-12-29
Clinical trial
Feasibility of High Daily Dose Short Course Primaquine After G6PD Testing for the Radical Cure of Plasmodium Vivax MalariaStatus: Recruiting, Estimated PCD: 2025-05-31
Clinical trial
Efficacy and Safety of Artemether-lumefantrine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria and Chloroquine for Plasmodium Vivax in the Philippines From 2013-2014Status: Completed, Estimated PCD: 2014-12-30
Product
Arthemeter-lumefantrineClinical trial
Safety and Efficacy of Different Regimens of Primaquine on Vivax Malaria Treatment in Glucose 6-phosphate Dehydrogenase Deficient PatientsStatus: Active (not recruiting), Estimated PCD: 2023-07-01